These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

682 related items for PubMed ID: 12111472

  • 21. Corpus callosum in Alzheimer's disease and vascular dementia--a quantitative magnetic resonance study.
    Pantel J, Schröder J, Essig M, Minakaran R, Schad LR, Friedlinger M, Jauss M, Knopp MV.
    J Neural Transm Suppl; 1998; 54():129-36. PubMed ID: 9850921
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Corpus callosum in neurodegenerative diseases: findings in Parkinson's disease.
    Wiltshire K, Foster S, Kaye JA, Small BJ, Camicioli R.
    Dement Geriatr Cogn Disord; 2005; 20(6):345-51. PubMed ID: 16192724
    [Abstract] [Full Text] [Related]

  • 24. Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer's disease.
    Meguro K, Blaizot X, Kondoh Y, Le Mestric C, Baron JC, Chavoix C.
    Brain; 1999 Aug; 122 ( Pt 8)():1519-31. PubMed ID: 10430835
    [Abstract] [Full Text] [Related]

  • 25. Callosal atrophy in mild cognitive impairment and Alzheimer's disease: different effects in different stages.
    Di Paola M, Luders E, Di Iulio F, Cherubini A, Passafiume D, Thompson PM, Caltagirone C, Toga AW, Spalletta G.
    Neuroimage; 2010 Jan 01; 49(1):141-9. PubMed ID: 19643188
    [Abstract] [Full Text] [Related]

  • 26. Callosal circularity as an early marker for Alzheimer's disease.
    Van Schependom J, Niemantsverdriet E, Smeets D, Engelborghs S.
    Neuroimage Clin; 2018 Jan 01; 19():516-526. PubMed ID: 29984160
    [Abstract] [Full Text] [Related]

  • 27. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM.
    Am J Psychiatry; 2002 May 01; 159(5):738-45. PubMed ID: 11986126
    [Abstract] [Full Text] [Related]

  • 28. White matter damage of patients with Alzheimer's disease correlated with the decreased cognitive function.
    Duan JH, Wang HQ, Xu J, Lin X, Chen SQ, Kang Z, Yao ZB.
    Surg Radiol Anat; 2006 May 01; 28(2):150-6. PubMed ID: 16614789
    [Abstract] [Full Text] [Related]

  • 29. White matter magnetic resonance imaging hyperintensity in Alzheimer's disease: correlations with corpus callosum atrophy.
    Vermersch P, Roche J, Hamon M, Daems-Monpeurt C, Pruvo JP, Dewailly P, Petit H.
    J Neurol; 1996 Mar 01; 243(3):231-4. PubMed ID: 8936352
    [Abstract] [Full Text] [Related]

  • 30. [Atrophy and magnetization transfer ratio of the corpus callosum in patients with Alzheimer's disease].
    Imon Y, Hanyu H, Iwamoto T, Takasaki M, Abe K.
    Rinsho Shinkeigaku; 1998 Dec 01; 38(12):1014-8. PubMed ID: 10349341
    [Abstract] [Full Text] [Related]

  • 31. Corpus callosum atrophy in patients with mild Alzheimer's disease.
    Frederiksen KS, Garde E, Skimminge A, Ryberg C, Rostrup E, Baaré WF, Siebner HR, Hejl AM, Leffers AM, Waldemar G.
    Neurodegener Dis; 2011 Dec 01; 8(6):476-82. PubMed ID: 21659724
    [Abstract] [Full Text] [Related]

  • 32. Topographic patterns of white matter hyperintensities are associated with multimodal neuroimaging biomarkers of Alzheimer's disease.
    Gaubert M, Lange C, Garnier-Crussard A, Köbe T, Bougacha S, Gonneaud J, de Flores R, Tomadesso C, Mézenge F, Landeau B, de la Sayette V, Chételat G, Wirth M.
    Alzheimers Res Ther; 2021 Jan 18; 13(1):29. PubMed ID: 33461618
    [Abstract] [Full Text] [Related]

  • 33. Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia.
    Bourgeat P, Chételat G, Villemagne VL, Fripp J, Raniga P, Pike K, Acosta O, Szoeke C, Ourselin S, Ames D, Ellis KA, Martins RN, Masters CL, Rowe CC, Salvado O, AIBL Research Group.
    Neurology; 2010 Jan 12; 74(2):121-7. PubMed ID: 20065247
    [Abstract] [Full Text] [Related]

  • 34. Regionally specific atrophy of the corpus callosum in AD, MCI and cognitive complaints.
    Wang PJ, Saykin AJ, Flashman LA, Wishart HA, Rabin LA, Santulli RB, McHugh TL, MacDonald JW, Mamourian AC.
    Neurobiol Aging; 2006 Nov 12; 27(11):1613-7. PubMed ID: 16271806
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ, DeSanti S, Zinkowski R, Mehta PD, Pratico D, Segal S, Clark C, Kerkman D, DeBernardis J, Li J, Lair L, Reisberg B, Tsui W, Rusinek H.
    J Intern Med; 2004 Sep 12; 256(3):205-23. PubMed ID: 15324364
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Callosal degeneration topographically correlated with cognitive function in amnestic mild cognitive impairment and Alzheimer's disease dementia.
    Wang PN, Chou KH, Chang NJ, Lin KN, Chen WT, Lan GY, Lin CP, Lirng JF.
    Hum Brain Mapp; 2014 Apr 12; 35(4):1529-43. PubMed ID: 23670960
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.